Resolution of Sinus Tachycardia Secondary to Hyperthyroidism With Ivabradine.
Electrophysiology
Hyperthyroidism
Tachyarrhythmia
Tachycardia
Journal
Journal of clinical medicine research
ISSN: 1918-3003
Titre abrégé: J Clin Med Res
Pays: Canada
ID NLM: 101538301
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
06
05
2023
accepted:
06
06
2023
medline:
12
7
2023
pubmed:
12
7
2023
entrez:
12
7
2023
Statut:
ppublish
Résumé
Currently, ivabradine is not approved for the treatment of sinus tachycardia secondary to hyperthyroidism. We aimed to increase the recognition of ivabradine as an effective alternative to, or combination with, beta-blockers in controlling sinus tachycardia secondary to hyperthyroidism. Elevated thyroid hormone levels enhance cardiac performance through a positive chronotropic effect, resulting in an increased heart rate (HR), an effect brought on by increasing the
Identifiants
pubmed: 37434775
doi: 10.14740/jocmr4940
pmc: PMC10332879
doi:
Types de publication
Case Reports
Langues
eng
Pagination
336-339Informations de copyright
Copyright 2023, Medina et al.
Déclaration de conflit d'intérêts
None to declare.
Références
Int J Clin Pract. 2006 Feb;60(2):222-8
pubmed: 16451297
Arch Med Sci. 2013 Oct 31;9(5):944-52
pubmed: 24273583
Lancet. 2010 Sep 11;376(9744):875-85
pubmed: 20801500
J Clin Endocrinol Metab. 1996 Aug;81(8):2828-35
pubmed: 8768838
Intern Med J. 2016 Aug;46(8):875-83
pubmed: 27059112
Heart Vessels. 2013 Jul;28(4):524-35
pubmed: 23142972
J Clin Endocrinol Metab. 2000 Dec;85(12):4701-5
pubmed: 11134131
Drugs. 2007;67 Suppl 2:15-24
pubmed: 17999560
J Cardiovasc Pharmacol Ther. 2013 Jul;18(4):338-44
pubmed: 23426376
J Am Coll Cardiol. 2017 Oct 3;70(14):1777-1784
pubmed: 28958335
Pflugers Arch. 2009 Oct;458(6):1061-8
pubmed: 19629520